Title: Hypopigmentary effects of 4-n-butylresorcinol and resveratrol in combination.
Journal: Die Pharmazie 20120601
Title: Adamantyl N-benzylbenzamide: new series of depigmentation agents with tyrosinase inhibitory activity.
Journal: Bioorganic & medicinal chemistry letters 20120301
Title: Topical hypopigmenting agents for pigmentary disorders and their mechanisms of action.
Journal: Annals of dermatology 20120201
Title: Efficacy and safety of liposome-encapsulated 4-n-butylresorcinol 0.1% cream for the treatment of melasma: a randomized controlled split-face trial.
Journal: The Journal of dermatology 20100401
Title: The Efficacy and Safety of 4-n-butylresorcinol 0.1% Cream for the Treatment of Melasma: A Randomized Controlled Split-face Trial.
Journal: Annals of dermatology 20100201
Title: Quasi-drugs developed in Japan for the prevention or treatment of hyperpigmentary disorders.
Journal: International journal of molecular sciences 20100101
Title: Studies on depigmenting activities of dihydroxyl benzamide derivatives containing adamantane moiety.
Journal: Bioorganic & medicinal chemistry letters 20090301
Title: Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial.
Journal: The British journal of dermatology 20070501
Title: Inhibitory effects of 4-n-butylresorcinol on tyrosinase activity and melanin synthesis.
Journal: Biological & pharmaceutical bulletin 20051201
Title: Jiang Y, et al. Synthesis and biological evaluation of unsymmetrical curcumin analogues as tyrosinaseinhibitors. Molecules. 2013 Apr 3;18(4):3948-61.
Title: Kim DS, et al. Inhibitory effects of 4-n-butylresorcinol on tyrosinase activity and melanin synthesis. Biol Pharm Bull. 2005 Dec;28(12):2216-9.
